|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Cash and due from banks | ||||
| Federal funds sold | ||||
| Interest-bearing deposits in banks | ||||
| Cash and cash equivalents | ||||
| Available-for-sale securities | ||||
| Held-to-maturity securities | ||||
| Loans, net of allowance for credit losses of $18,722,469 and$18,096,173 on June 30, 2026 and December 31, 2025, respectively | ||||
| Premises and equipment, net | ||||
| Restricted stock, at cost | ||||
| Foreclosed assets held for sale, net | ||||
| Interest receivable | ||||
| Bank owned life insurance | ||||
| Core deposits and other intangibles | ||||
| Goodwill | ||||
| Deferred tax asset | ||||
| Other | ||||
| Total assets | ||||
| Liabilities | ||||
| Demand | ||||
| Savings, NOW and money market | ||||
| Time | ||||
| Total deposits | ||||
| Short-term borrowings | ||||
| Long-term debt | ||||
| Interest payable | ||||
| Other liabilities | ||||
| Total liabilities | ||||
| Shareholders’ equity | ||||
| Common stock $0.01 par value; 50,000,000 shares authorized; 13,701,270 shares issued and outstanding on June 30, 2026; 13,697,987 on December 31, 2025 | ||||
| Additional paid-in capital | ||||
| Retained earnings | ||||
| Accumulated other comprehensive loss | ||||
| Total shareholders’ equity | ||||
| Total liabilities and shareholders’ equity |
Loading...
